Nema internetske veze — prikazuje se spremljena verzija stranice.

Organon & Co

USUSD
← Na Filtar Dionica

Organon & Co (LSE:0A9W) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 2. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
organon.com
Odnosi s Investitorima
organon.com/investor-relations/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sjedište
Oss, United States
Glavni Direktor
Joseph T. Morrissey
Zaposlenici
10 000
Osnovana
1923
Dionice u Optjecaju
262.61 mil. na dan 2026-07-24
1 Godina: +1.0% · 3 godine: +2.8% · 5 godina: +3.6% (bez podjela dionica)
DatumDionicePromjena
24.07.2026262.61 mil.—nema značajnih promjena
27.04.2026262.6 mil.+0.9%izdavanje (razvodnjavanje)
17.02.2026260.32 mil.+0.1%izdavanje (razvodnjavanje)
03.11.2025259.98 mil.—nema značajnih promjena
30.07.2025259.97 mil.—nema značajnih promjena
25.04.2025259.96 mil.+0.8%izdavanje (razvodnjavanje)
25.02.2025257.95 mil.+0.2%izdavanje (razvodnjavanje)
25.10.2024257.54 mil.+0.03%nema značajnih promjena
30.07.2024257.47 mil.+0.1%izdavanje (razvodnjavanje)
26.04.2024257.17 mil.+0.6%izdavanje (razvodnjavanje)
20.02.2024255.64 mil.+0.01%nema značajnih promjena
27.10.2023255.61 mil.+0.01%nema značajnih promjena
04.08.2023255.57 mil.+0.2%izdavanje (razvodnjavanje)
28.04.2023255.06 mil.+0.3%izdavanje (razvodnjavanje)
22.02.2023254.38 mil.—nema značajnih promjena
Broj dionica prema izvješćima tvrtke. Podjela dionica prepoznaje se po skoku broja za cijeli broj puta.
Slobodno Prenosive Dionice
242.99 mil.
Tržišna Kapitalizacija
3.6 mlrd. USD
Insajderi
0.46%
Institucionalni Ulagači
84.8%
Djelatnost (SIC)
Pharmaceutical Preparations
ISIN
US68622V1061
LEI
549300AMCKY57OK2CO56
P/E
17.3
Omjer Isplate
8.6%
FCF
567 mil. USD
Isplata / FCF
3%
Dug
8.55 mlrd. USD
13 g. FCF
Dividendni Staž
5 g.
Zarada, FCF i isplaćene dividende — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
NAV
3.83 USD · P/NAV 3.58
Datum Bilance30.06.2026
Imovina13.2 mlrd. USD
− Obveze12.2 mlrd. USD
= NAV (Kapital Dioničara Tvrtke)1.01 mlrd. USD
− Goodwill4.15 mlrd. USD
− Nematerijalna Imovina1.11 mlrd. USD
= Materijalna NAV−4.26 mlrd. USD
Dionice262 609 000
NAV po Dionici3.83 USD
Opipljivi NAV po Dionici−16.22 USD
Cijena Dionice (0A9W)13.7300 USD
P/NAV3.58
Povijest NAV-a
Datum BilanceNAVNAV po Dionici
30.06.20261.01 mlrd. USD3.83 USD
31.03.2026903 mil. USD3.44 USD
31.12.2025752 mil. USD2.89 USD
30.09.2025906 mil. USD3.48 USD
30.06.2025733 mil. USD2.82 USD
31.03.2025542 mil. USD2.10 USD
31.12.2024472 mil. USD1.83 USD
30.09.2024493 mil. USD1.91 USD
Opis

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksOGN glavnaUSD13.75 -0.07%obične dionice
LSE London Stock Exchange0A9W IOBUSD13.73 +0.07%obične dionice

Cijena za 3 Mjeseca

dan rasta dan pada ex-dividendni datum datum isplatePrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Dividende

Godišnje, LSE:0A9W: 0.08 USD (4 ispl.)

Organon & Co (0A9W) isplaćuje dividende kvartalno. Godišnje (12 mjeseci do uključivo posljednje najavljene isplate): 0.08 USD po dionici (isplata: 4). To je otprilike 0.58% trenutne cijene dionice. Prema povijesti isplata, sljedeći datum ex-dividende očekuje se oko 17.11.2026. Godine neprekinutih dividendi: 5.

Ex-DatumIsplataIznos%VrstaOznaka
2026-08-142026-09-100.0200 USD0.1/0.6 %tromjesečnoLSE:0A9W
2026-05-112026-06-110.0200 USD0.2/0.6 %tromjesečnoLSE:0A9W
2026-02-232026-03-120.0200 USD0.3/1.0 %tromjesečnoLSE:0A9W
2025-11-202025-12-110.0200 USD0.3/4.6 %tromjesečnoLSE:0A9W
2025-08-152025-09-110.0200 USD0.2/6.5 %tromjesečnoLSE:0A9W
2025-05-122025-06-120.0200 USD0.2/9.7 %tromjesečnoLSE:0A9W
2025-02-212025-03-130.2800 USD1.8/7.2 %tromjesečnoLSE:0A9W
2024-11-122024-12-120.2800 USD1.5/6.0 %tromjesečnoLSE:0A9W
2024-08-162024-09-120.2800 USD1.5/6.0 %tromjesečnoLSE:0A9W
2024-05-102024-06-130.2800 USD1.5/6.0 %tromjesečnoLSE:0A9W
2024-02-232024-03-140.2800 USD1.5/6.0 %tromjesečnoLSE:0A9W
2023-11-102023-12-140.2800 USD2.4/9.8 %tromjesečnoLSE:0A9W
2023-08-17—0.2800 USD1.2/4.9 %tromjesečnoLSE:0A9W
2023-05-12—0.2800 USD1.3/5.3 %tromjesečnoLSE:0A9W
2023-02-24—0.2800 USD1.1/4.2 %tromjesečnoLSE:0A9W
2022-11-10—0.2800 USD1.2/4.7 %tromjesečnoLSE:0A9W
2022-08-12—0.2800 USD0.9/3.5 %tromjesečnoLSE:0A9W
2022-05-13—0.2800 USD0.8/2.4 %tromjesečnoLSE:0A9W
2022-02-25—0.2800 USD0.8/1.6 %tromjesečnoLSE:0A9W
2021-11-19—0.2800 USD0.9/0.9 %tromjesečnoLSE:0A9W

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
Blackrock Inc.12.21%32.06 mil.2026-06-30
Pentwater Capital Manage…6.89%18.1 mil.2026-06-30
iShares Trust-iShares Co…6.09%16 mil.2026-08-31
Vanguard Portfolio Manag…5.76%15.13 mil.2026-06-30
Vanguard Capital Managem…4.54%11.91 mil.2026-06-30
State Street Corporation3.68%9.66 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%8.33 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%6.02 mil.2026-06-30
Goldman Sachs Group Inc1.98%5.2 mil.2026-06-30
UBS Group AG1.85%4.86 mil.2026-06-30
Geode Capital Management…1.83%4.82 mil.2026-06-30
Alliancebernstein L.P.1.81%4.75 mil.2026-06-30
Man Group PLC1.59%4.18 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…1.45%3.82 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…1.15%3.01 mil.2026-06-30
NexPoint Funds I-NexPoin…1.03%2.71 mil.2026-06-30
SPDR SERIES TRUST-State…0.94%2.47 mil.2026-08-31
iShares Trust-iShares S&…0.89%2.35 mil.2026-08-31
SPDR SERIES TRUST-State…0.54%1.41 mil.2026-08-31
Fidelity Concord Street…0.49%1.3 mil.2026-07-31
ALI KEVIN (Chief Executi…≈0.11%282 7312025-05-05
WALSH MATTHEW M (Chief F…≈0.08%212 7462026-03-31
MORRISSEY JOSEPH T JR (C…≈0.05%123 1232026-03-31
STAHLER RACHEL A (Chief…≈0.04%116 1052026-03-31
FALCIONE AARON (Officer)≈0.04%101 4312026-03-31
WEAVER KIRKE (General Co…≈0.04%92 6392026-03-31
NISITA VITTORIO (Officer…≈0.03%70 6192026-03-31
KARP DANIEL (Officer)≈0.03%69 5472026-03-31
HOLZBAUR LYNETTE (Office…≈0.02%52 8502026-05-06
COX CARRIE SMITH (Office…——2025-11-12